Prognostic Significance of MYC Rearrangement and Translocation Partner in DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
J. Clin. Oncol 2019 Sep 09;[EPub Ahead of Print], A Rosenwald, S Bens, R Advani, S Barrans, C Copie-Bergman, MH Elsensohn, Y Natkunam, M Calaminici, B Sander, M Baia, A Smith, D Painter, L Pham, S Zhao, M Ziepert, ES Jordanova, TJ Molina, MJ Kersten, E Kimby, W Klapper, J Raemaekers, N Schmitz, F Jardin, WBC Stevens, E Hoster, A Hagenbeek, JG Gribben, R Siebert, RD Gascoyne, DW Scott, P Gaulard, G Salles, C Burton, D de Jong, LH Sehn, D Maucort-BoulchFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.